fr

CARMAT announces the first commercial implants of its Aeson® artificial heart outside the European Union

CARMAT publishes its third Shareholder Newsletter

Download

Financial agenda 2013

Download

Recent participations in two scientific conferences

Download

2012 half-year results

Download

CARMAT publishes its second Shareholder Newsletter

Download

Further elements added to the ANSM file

Download

CARMAT wins the Best technology category at the European Mediscience Awards

Download

FYR 2011: a sound cash position of €29.4m at 31.12.2011

Download
Top of page